FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073156664> ?p ?o ?g. }

• W2073156664 endingPage "35" @default.
• W2073156664 startingPage "25" @default.
• W2073156664 abstract "Postherpetic neuralgia (PHN) is a separate disease entity that represents a complication of acute herpes zoster. PHN, involving aberrant somatosensory processing in the peripheral and/or central nervous system, is considered to be a chronic neuropathic pain, frequently unresponsive to all treatment modalities. Despite the clinical trial data demonstrating successful pain relief with several drug regimens, the pharmacologic management of neuropathic pain is difficult, particularly in PHN. Response to therapy is generally inhomogeneous. Some patients experience long-term pain control with either topical or oral monotherapy with antidepressants, anticonvulsants, or opioids. Other PHN patients, such as those suffering pain due to central nervous system lesions, are extraordinarily refractory to all measures. This article will review current treatments--tricyclic antidepressants, anticonvulsants, local anesthetics, clonidine, N-methyl-D-aspartate (NMDA)-antagonists, and opioids and focus on mechanism-based pharmacologic interventions. Pharmacologic approaches can be classified into three groups: 1) drugs that act topically in the affected skin area; 2) drugs that act on nerve excitability and conduction in sensory axons; and 3) drugs that act on neural damage related synaptic changes. This last group is the only pain treatment option related to central denervation. To date, the treatment of PHN has relied on the use of tricyclic antidepressants (TCAs), which represent the most comprehensively studied medications for this pain syndrome. Clinical data indicate that TCAs are effective analgesics in approximately 50% of patients; these drugs have been recommended as first-line agents for all neuropathic pain syndromes except trigeminal neuralgia, but are frequently contraindicated or poorly tolerated in elderly patients with PHN. If monotherapy fails, a mechanism- and/or symptom-based multidrug regimen can be used. There is also consistent support for intravenous and topical lidocaine, intravenous ketamine, carbamazepine, and opioids. Gabapentin, a new anticonvulsant, can be considered a first-line oral medication for PHN based on the efficacy and safety results of a recently completed double-blind trial. In addition to positive effects on PHN, sleep, mood, and overall quality of life were significantly improved." @default.
• W2073156664 created "2016-06-24" @default.
• W2073156664 creator A5050977362 @default.
• W2073156664 creator A5067966454 @default.
• W2073156664 date "1999-10-01" @default.
• W2073156664 modified "2023-09-26" @default.
• W2073156664 title "Treatment options in postherpetic neuralgia" @default.
• W2073156664 cites W1511198581 @default.
• W2073156664 cites W156783501 @default.
• W2073156664 cites W1964941904 @default.
• W2073156664 cites W1965966154 @default.
• W2073156664 cites W1966476039 @default.
• W2073156664 cites W1968535715 @default.
• W2073156664 cites W1971340456 @default.
• W2073156664 cites W1981829400 @default.
• W2073156664 cites W1982324672 @default.
• W2073156664 cites W1982357122 @default.
• W2073156664 cites W1989605175 @default.
• W2073156664 cites W1991353203 @default.
• W2073156664 cites W1993369032 @default.
• W2073156664 cites W1995856060 @default.
• W2073156664 cites W2001187037 @default.
• W2073156664 cites W2002407299 @default.
• W2073156664 cites W20048007 @default.
• W2073156664 cites W2008246414 @default.
• W2073156664 cites W2011900593 @default.
• W2073156664 cites W2012129281 @default.
• W2073156664 cites W2013521922 @default.
• W2073156664 cites W2018652055 @default.
• W2073156664 cites W2025009198 @default.
• W2073156664 cites W2027111558 @default.
• W2073156664 cites W2030094128 @default.
• W2073156664 cites W2031115386 @default.
• W2073156664 cites W2031696742 @default.
• W2073156664 cites W2033573454 @default.
• W2073156664 cites W2038770613 @default.
• W2073156664 cites W2039982019 @default.
• W2073156664 cites W2044726319 @default.
• W2073156664 cites W2044993804 @default.
• W2073156664 cites W2045888529 @default.
• W2073156664 cites W2062270592 @default.
• W2073156664 cites W2064105320 @default.
• W2073156664 cites W2064753610 @default.
• W2073156664 cites W2066869040 @default.
• W2073156664 cites W2071709883 @default.
• W2073156664 cites W2075885147 @default.
• W2073156664 cites W2076696791 @default.
• W2073156664 cites W2081887464 @default.
• W2073156664 cites W2089183587 @default.
• W2073156664 cites W2094898453 @default.
• W2073156664 cites W2098947546 @default.
• W2073156664 cites W2106564152 @default.
• W2073156664 cites W2116876133 @default.
• W2073156664 cites W2118526319 @default.
• W2073156664 cites W2118649138 @default.
• W2073156664 cites W2128839982 @default.
• W2073156664 cites W2136568920 @default.
• W2073156664 cites W2136743000 @default.
• W2073156664 cites W2137352602 @default.
• W2073156664 cites W2138860183 @default.
• W2073156664 cites W2167805515 @default.
• W2073156664 cites W2322450883 @default.
• W2073156664 cites W2330562239 @default.
• W2073156664 cites W2415543228 @default.
• W2073156664 cites W2443472429 @default.
• W2073156664 cites W2464690778 @default.
• W2073156664 cites W4251782537 @default.
• W2073156664 cites W4376848786 @default.
• W2073156664 cites W87067304 @default.
• W2073156664 cites W989792163 @default.
• W2073156664 doi "https://doi.org/10.1111/j.1600-0404.1999.tb07387.x" @default.
• W2073156664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10819089" @default.
• W2073156664 hasPublicationYear "1999" @default.
• W2073156664 type Work @default.
• W2073156664 sameAs 2073156664 @default.
• W2073156664 citedByCount "58" @default.
• W2073156664 countsByYear W20731566642012 @default.
• W2073156664 countsByYear W20731566642014 @default.
• W2073156664 countsByYear W20731566642015 @default.
• W2073156664 countsByYear W20731566642016 @default.
• W2073156664 countsByYear W20731566642017 @default.
• W2073156664 countsByYear W20731566642018 @default.
• W2073156664 countsByYear W20731566642019 @default.
• W2073156664 countsByYear W20731566642022 @default.
• W2073156664 countsByYear W20731566642023 @default.
• W2073156664 crossrefType "journal-article" @default.
• W2073156664 hasAuthorship W2073156664A5050977362 @default.
• W2073156664 hasAuthorship W2073156664A5067966454 @default.
• W2073156664 hasBestOaLocation W20731566641 @default.
• W2073156664 hasConcept C126322002 @default.
• W2073156664 hasConcept C142724271 @default.
• W2073156664 hasConcept C170493617 @default.
• W2073156664 hasConcept C204787440 @default.
• W2073156664 hasConcept C2776468701 @default.
• W2073156664 hasConcept C2776608144 @default.
• W2073156664 hasConcept C2777107010 @default.
• W2073156664 hasConcept C2778866549 @default.
• W2073156664 hasConcept C2780016216 @default.

• next